An inward rectifier potassium current, Kir, has been identified in cerebral and coronary resistance vessels, where it is considered to be an important determinant of resting membrane potential (RMP) and to play a role in blood flow regulation. We investigated the functional role of Kir in the renal afferent arteriole using the in vitro-perfused hydronephrotic rat kidney. Increasing external KCl from 5 to 15 mmol/L induced afferent arteriolar vasodilation. This response was inhibited by 10 to 100 mol/L Ba 2ϩ , concentrations selective for blockade of Kir, and by chloroethylclonidine (100 mol/L) but was not blocked by glibenclamide (10 mol/L) or ouabain (3 mmol/L). Reducing external KCl from 5 to 1.5 mmol/L to enhance rectification of Kir caused vasoconstriction at low renal arterial pressure (40 mm Hg) and vasodilation during myogenic vasoconstriction (120 mm Hg), suggesting that this current dominates RMP at low perfusion pressures. When administered to kidneys perfused at 40 mm Hg renal arterial pressure, 30 mol/L Ba 2ϩ elicited afferent arteriolar depolarization, reducing RMP from Ϫ47Ϯ2 to Ϫ34Ϯ2 mV (nϭ10, PϽ0.0001), and vasoconstriction, reducing diameters from 14.5Ϯ1 to 10.9Ϯ0.8 m (nϭ10, Pϭ0.0016). Although Ba 2ϩ reduced resting diameter, blockade of Kir did not prevent myogenic signaling in this vessel. Our findings thus demonstrate the presence of Kir in rat renal afferent arterioles and suggest that this current is an important determinant of RMP in situ. (Circ Res. 2001;88:152-158.)
O f the 4 classes of K ϩ channels known to regulate vascular smooth muscle tone, the inward rectifier, Kir, is the least characterized. This is attributable in part to its restricted expression in resistance vessels. Kir is absent in most large conduit vessels. However, the density of Kir and its physiological importance may increase with decreasing vessel caliber. [1] [2] [3] Although Kir has been identified in submucosal, 4 carotid, 5 cerebral, 2, 6 and coronary arteries, 6 the role of Kir in the renal microcirculation has not been studied. Prior et al 7 concluded that Kir does not play a functional role in regulation of tone in rabbit renal arcuate arteries. However, the arcuate is not a resistance vessel. Renal vascular resistance is determined predominantly by the afferent and efferent arterioles. 8 The afferent arteriole is the terminal resistance vessel upstream of the glomerulus and, by regulating preglomerular resistance, plays the major role in renal autoregulation and the control of glomerular capillary pressure.
K ϩ -induced vasodilation has long been recognized as a mechanism for regulating local blood supply. In general, modest increases in local K ϩ concentration result in vasodilation and increased blood flow. 9 This vasodilation is mediated, in part, by the outward current carried by Kir. Patchclamp studies using smooth-muscle myocytes from vessels exhibiting K ϩ -induced dilation demonstrate that elevations in external K ϩ increase outward current through Kir. 10 -12 This effect is attributable to a displacement by K ϩ of polyamine or Mg 2ϩ binding within the pore, which reduces rectification and increases outward current. 13 An alternate mechanism whereby external K ϩ can induce vasodilation is by stimulating the ouabain-sensitive, electrogenic Na ϩ -K ϩ ATPase. 6, 7, 14 Ba 2ϩ blocks Kir at micromolar concentrations and can be used to distinguish Kir-induced vasodilation from effects mediated by other K ϩ channels or from ouabain-sensitive vasodilation. 10 -12,14 In addition, the ␣-adrenoceptor agonist/antagonist chloroethylclonidine (CEC) has recently been shown to block Kir. 15 Hence, the combination of K ϩ -induced vasodilation together with micromolar sensitivity to Ba 2ϩ and lack of effect of ouabain provides reasonable evidence for a functional role of Kir in intact vessels.
In the present study, the role of Kir in the renal afferent arteriole was investigated using the in vitro-perfused hydronephrotic rat kidney preparation. 16 We determined the ability of 15 mmol/L KCl to dilate the afferent arteriole and the effects of Ba 2ϩ , CEC, and ouabain on this response. The contribution of Kir to resting membrane potential (RMP) was assessed by simultaneously measuring afferent arteriolar RMP and diameter during blockade of Kir. Finally, we examined the impact of blocking Kir on myogenic reactivity. Our findings provide the first evidence of a functional role for Kir in the renal microcirculation.
Materials and Methods
The in vitro hydronephrotic rat kidney 16 was used to examine the role of Kir in the afferent arteriole. Use of animals complied with Canadian Council on Animal Care regulations. Unilateral hydronephrosis was induced in male Sprague-Dawley rats by ligating the left ureter under halothane anesthesia. Rats were obtained from the Animal Resource Center breeding facility at the University of Calgary. Kidneys were harvested after 6 weeks, when tubular atrophy had advanced to a stage allowing direct visualization of the renal microvasculature. The renal artery was cannulated, and the kidney was excised with continuous perfusion. Kidneys were perfused with modified DMEM (GIBCO) at 37°C, equilibrated with 5% CO 2 , containing (in mmol/L) Ca 2ϩ 1.6, bicarbonate 30, glucose 5, pyruvate 1, and HEPES 5. Endogenous prostanoids modulate vascular reactivity in both normal kidneys and in our model. 16 Therefore, 10 mol/L ibuprofen was included in the perfusate. Perfusion pressure was monitored at the level of the renal artery and was controlled by adjusting pressure within the perfusion reservoir. Kidneys were allowed 1 hour to recover before initiation of experimental protocols. Diameters were measured by online image processing.
Afferent arteriolar RMPs were measured as described previously. 17 Hydronephrotic kidneys were excised as described above. The capsule was removed, and the perfused kidney was mounted on a Plexiglas post, allowing access to the surface. A custom microscope with a water-immersion ceramic objective, coupled to a projection lens and video system, provided high magnification for impalements and diameter measurements. A microelectrode (2 mmol/L KCl and beveled at 30°to 80 to 100 M⍀) was placed within a patch-type pipette (tip diameter 10 to 20 m) using a custom holder with motorized positioner. The patch pipette was then positioned against the vessel wall and held with suction to stabilize the impalement site. A piezo device was used to impale the vessel. We have shown that RMP measurements obtained using this approach are similar to those obtained using conventional microelectrodes. 17 An impalement was considered successful if each of the following criteria were met: sudden negative deflection in membrane potential, stable recording of membrane potential for at least 1 minute before treatment with Ba 2ϩ , and no change in microelectrode tip resistance on withdrawal. The effects of Ba 2ϩ on RMP and diameter were recorded simultaneously using this approach.
Glibenclamide and ibuprofen were obtained from Research Biochemicals International. All other chemicals were obtained from Sigma. KCl solutions 10 and 15 mmol/L were prepared by isotonic substitution for NaCl. Ouabain was made fresh for each experiment (3 mmol/L in DMEM). Phentolamine and propranolol were added during the ouabain experiment to avoid effects mediated by neurotransmitter release and to the CEC experiments to avoid effects of adrenoceptor modulation.
Data are expressed as meanϮSEM. The number of replicates (n) refers to the number of vessels. Generally, no more than 2 vessels were studied per kidney (where appropriate, N refers to number of kidneys). Differences between means were evaluated by Student's paired t test unless otherwise noted. PϽ0.05 was considered significant. Figure 1 illustrates the vasodilator response of an afferent arteriole to 15 mmol/L KCl. Vasoconstriction was induced by elevating renal arterial pressure (RAP) from 80 to 160 mm Hg, reducing diameters from 16.3Ϯ0.4 to 8.1Ϯ0.5 m (nϭ25, PϽ0.0001). In this setting, 15 mmol/L KCl caused afferent arteriolar dilation to 13.6Ϯ0.5 m (PϽ0.0001). Returning to 5 mmol/L KCl restored myogenic vasoconstriction to previous levels (8.5Ϯ0.5 m, Pϭ0. 26) .
Results
We next assessed the effects of Ba 2ϩ and CEC on K ϩinduced vasodilation. The control studies presented in Figure  2A illustrate that repetitive K ϩ -induced responses were stable over time. As shown in Figure 2B , Ba 2ϩ attenuated this response in a concentration-dependent manner. Ba 2ϩ also reduced basal diameters (considered in detail below), precluding a calculation of the ED 50 . Nevertheless, Ba 2ϩ reduced the K ϩ -induced dilation over concentrations that selectively block Kir 10 -12 (10 to 100 mol/L). Complete blockade was observed at 100 mol/L (Pϭ0.54, nϭ6). At 100 mol/L, Ba 2ϩ may block ATP-sensitive K ϩ channels (K ATP ). 14 However, glibenclamide had no effect. Thus, 15 mmol/L KCl increased diameters from 8Ϯ1.4 to 15.1Ϯ2.1 m in the presence of vehicle (ethanol) and from 8.3Ϯ2.6 to 15.1Ϯ2.5 m in the presence of 10 mol/L glibenclamide (nϭ3, Pϭ0.9). The K ϩ -induced dilation was also blocked by 100 mol/L CEC, an agent recently shown to block Kir 15 ( Figure  2C ). Before application of CEC, 15 mmol/L K ϩ induced dilation in preconstricted arterioles (9.5Ϯ1.6 versus 15.5Ϯ0.9 m with 15 mmol/L KCl, RAPϭ140 mm Hg, nϭ5). CEC caused additional constriction, reducing diameters to 6.4Ϯ1.1 m, and completely blocked the K ϩ -induced dilation. Notably, application of 15 mmol/L KCl during CEC treatment caused additional constriction (to 4.9Ϯ1.1 m, nϭ5), consistent with the change in the K ϩ equilibrium potential.
The above findings suggest that the K ϩ -induced dilation is mediated by Kir on the basis of the effects of Ba 2ϩ and CEC. We next examined the effects of blockade of the Na ϩ -K ϩ ATPase. Vessels were preconstricted by administering 3 mmol/L ouabain (RAP 80 mm Hg), a concentration sufficient to block the rat isoform. 14 Kidneys were pretreated with phentolamine and propranolol (10 mol/L) to prevent effects attributable to the release of neurotransmitters. As shown in Figure 3 , ouabain reduced diameters from 16.3Ϯ1.5 to 4.2Ϯ1.5 m (nϭ4, Pϭ0.022), but K ϩ -induced vasodilation was preserved (increasing diameters from 4.2Ϯ1.5 to 13.7Ϯ0.9 m, Pϭ0.0246). In these studies, 10 mmol/L KCl was used to allow for the decrease in internal [K ϩ ] induced by ouabain. When kidneys were treated with both 100 mol/L Ba 2ϩ and ouabain, diameters decreased from 18Ϯ0.9 to 3.8Ϯ1 m (nϭ4, Pϭ0.0033), and KCl-induced dilation was blocked (3.9Ϯ1.2 m, Pϭ0.56). The ability of Ba 2ϩ to block KCl-induced dilation was readily reversed when Ba 2ϩ was removed from the perfusate ( Figure 4A ).
Kir is thought to contribute to RMP and resting tone in other vessel types. 10 -12 We thus determined the effects of Ba 2ϩ blockade of Kir on resting diameter and RMP in the afferent arteriole. As shown in Figure 4B , Ba 2ϩ elicited a vasoconstrictor response of the afferent arteriole that was reversed on Ba 2ϩ removal. Ba 2ϩ blockade of Kir elicited dose-dependent vasoconstriction over concentrations of 1 to 100 mol/L. At 80 mm Hg, 30 mol/L Ba 2ϩ reduced afferent arteriolar diameter from 15.6Ϯ0.5 to 7.6Ϯ1.6 m (51Ϯ9% decrease, nϭ6, Pϭ0.0041). Half-maximal constriction (EC 50 ) was seen at 19Ϯ3 mol/L Ba 2ϩ ( Figure 5 ). As described below, Ba 2ϩ altered the threshold for myogenic vasoconstriction, shifting the response to lower pressures. We therefore characterized the effects of Ba 2ϩ at low perfusion pressure (40 mm Hg). Under these conditions, 30 mol/L Ba 2ϩ reduced RMP from Ϫ47Ϯ2 to Ϫ34Ϯ2 mV (PϽ0.0001) and reduced diameter from 14.5Ϯ1 to 10.9Ϯ0.8 m (nϭ10, Nϭ8, Pϭ0.002). These data are summarized in Figure 6 . These findings suggest an important role of Kir in the setting of RMP and basal tone in the afferent arteriole. However, this interpretation is based exclusively on the premise that 30 mol/L Ba 2ϩ selectively blocks Kir. To independently test this postulate, we examined the effects of reducing external K ϩ ([K ϩ ] o ). The inward rectification that is characteristic of Kir is attributed to polyamine or Mg 2ϩ block. Figure 7 , reducing [K ϩ ] o from 5 to 1.5 mmol/L induced a constriction at 40 mm Hg, reducing diameters from 15Ϯ0.6 to 12.8Ϯ0.9 m (nϭ6, Nϭ5, Pϭ0.0088). To rule out the possibility that lowering [K ϩ ] o induced vasoconstriction by reducing activity of the electrogenic Na ϩ -K ϩ ATPase, we conducted additional experiments in the presence of 3 mmol/L ouabain. The ouabaininduced vasoconstriction was minimized by reducing RAP to 30 mm Hg. In the presence of ouabain, lowering [K ϩ ] o from 5 to 1.5 mmol/L caused additional constriction, reducing diameters from 14Ϯ8.2 to 8.2Ϯ1.2 m (Pϭ0.0014, nϭ5). We next examined the effects of lowering [K ϩ ] o at elevated RAP, conditions in which channels other than Kir, such as voltage-or Ca 2ϩ -activated K ϩ channels (Kv and K Ca ), might be active. We have shown that K Ca is activated at elevated pressure, modulating myogenic vasoconstriction. 18 Elevating RAP from 80 to 120 mm Hg reduced afferent diameters from 15.8Ϯ0.8 to 9.9Ϯ0.8 m (nϭ6, Pϭ0.0008). In this setting, reducing [K ϩ ] o to 1.5 mmol/L increased diameters from 9.9Ϯ0.8 to 14.1Ϯ0.5 m (nϭ6, Pϭ0.0006). In concert with the Ba 2ϩ data, these observations provide compelling evidence that Kir is the predominant K ϩ channel responsible for setting resting afferent arteriolar tone at low levels of perfusion pressure.
Accordingly, alterations in Kir might contribute to myogenic activation. Therefore, we examined the effects of Ba 2ϩ on the myogenic response. As shown in Figure 8A , graded afferent vasoconstriction is elicited when RAP is increased from 20 to 180 mm Hg. Figure 8A additionally illustrates that in a series of time controls, 6 repeated challenges to increased renal arterial pressure (administered over a 7-hour period) elicited identical myogenic responses (nϭ4). As shown in Figure 8B , 1 to 100 mol/L Ba 2ϩ elicited vasoconstriction at low RAP but did not prevent additional constriction when RAP was increased. This is additionally illustrated in Figure  8C , which depicts the response as the percent change in diameter. Ba 2ϩ caused a leftward shift in the activation curve, perhaps reflecting the impact of blockade of Kir on basal tone and RMP. However, despite the Ba 2ϩ -induced preconstriction, the arterioles responded in an incremental manner to elevations in RAP, suggesting that Kir modulation is not a requisite component of myogenic signaling in this vessel.
Discussion
The present study provides the first evidence for a functional role of Kir in the renal afferent arteriole. We demonstrated that 15 mmol/L KCl elicits a vasodilation in this vessel and that this response was not prevented by ouabain but was sensitive to CEC and Ba 2ϩ at concentrations reported to selectively block Kir. Moreover, manipulations that would reduce Kir currents under basal conditions (30 mol/L Ba 2ϩ , low [K ϩ ] o ) elicit both depolarization and vasoconstriction, suggesting that Kir is a significant determinant of RMP and resting tone in the afferent arteriole.
The properties of the K ϩ -induced dilation in the afferent arteriole are similar to those attributed to Kir in other vessel types. Application of 6 to 16 mmol/L KCl to preconstricted isolated posterior cerebral arteries, 6, 14 middle cerebral arteries, 19 and coronary arteries 6 results in dilation, and this response is blocked by micromolar levels of Ba 2ϩ . In these preparations, as in the present study, neither ouabain nor glibenclamide prevented this response. Electrophysiological characterization of Kir in vascular smooth muscle was first reported by Hirst and Neild, 4 who described currents exhibiting inward rectification in submucosal arterioles of guinea pig ileum. Similar inwardly rectifying currents have been described in carotid artery 5 and middle cerebral arteriole. 20, 21 Studies using patch-clamp techniques have identified K ϩinduced increases in outward current and inhibition of this current by micromolar Ba 2ϩ in myocytes isolated from posterior cerebral artery 2,6 and coronary artery. 3, 6, 22 Recently, the targeted disruption of the Kir2.1 gene in mice was shown to be associated with a loss of both the inwardly rectifying K ϩ current and K ϩ -induced dilation in cerebral arteries, suggesting its essential role in the response. 23 Our finding that CEC inhibited K ϩ -induced vasodilation additionally supports a role for Kir. CEC is an irreversible agonist at ␣ 2 adrenoceptors and an antagonist at ␣ 1 adrenoceptors 24 but was recently reported to selectively inhibit inward rectifier K ϩ currents in skeletal muscle fibers and whole-cell K ϩ currents in cultured cell lines transfected with Kir2.1. 15 These effects did not involve adrenoceptors, because they were not mimicked or altered by adrenoceptor ligands and could be demonstrated in cells that do not express adrenoceptors. 15 Similarly, the inhibition of K ϩ -induced dilation by CEC in the afferent arteriole that we observed occurred in the presence of phentolamine and propranolol, indicating that adrenoceptors are not involved.
Two previous studies have addressed the possible role of Kir in the renal circulation. Kurtz and Penner 25 described inward rectifying K ϩ currents in mouse juxtaglomerular cells, renin-secreting cells in the terminal segment of the afferent arteriole. They recorded whole-cell currents that were sensitive to changes in external K ϩ but did not assess Ba 2ϩ sensitivity. More recently, Prior et al 7 evaluated the Ba 2ϩ and ouabain sensitivity of K ϩ -induced dilation of rabbit renal arcuate arteries. In contrast to our findings with the afferent arteriole, these authors found that K ϩ -induced dilation of the arcuate artery was attenuated by ouabain but not blocked by Ba 2ϩ , suggesting that Kir is not involved. As mentioned previously, Kir is thought to be more prevalent in resistance vessels than in conduit arteries, such as the arcuate artery. Our findings, together with those of Prior et al, 7 indicate that this pattern holds in the kidney.
In our studies, 30 mol/L Ba 2ϩ produced marked constriction of the afferent arteriole and membrane depolarization (13 mV) at low RAP, suggesting a role for Kir in maintaining RMP and resting tone. A more modest Ba 2ϩ -induced constriction (8%, from 208Ϯ7 to 191Ϯ19 m with 120 mol/L Ba 2ϩ ) was described in isolated perfused rat middle cerebral arteries by Johnson et al. 19 In our studies, Ba 2ϩ inhibited K ϩ -induced vasodilation at 10 to 100 mol/L and elicited vasoconstriction in the same concentration range (ED 50 ϭ19Ϯ3 mol/L). The ED 50 for Ba 2ϩ -induced vasoconstriction in the middle cerebral artery is Ϸ60 mol/L (see Figure 6 in Johnson et al). Similarly, the IC 50 for Ba 2ϩ block of K ϩ -induced dilation in middle cerebral arteries was 20 to 40 mol/L (see Figure 3 in Johnson et al 19 ) . These values are close to the range for Ba 2ϩ blockade of Kir channels. At Ϫ45 mV, the K d for Ba 2ϩinduced inhibition of Kir in posterior cerebral artery myocytes was estimated at 8 mol/L. 2, 6 Similar K d values, 3 mol/L 6 Ba 2ϩ and 4.7 mol/L 22 Ba 2ϩ at Ϫ40 mV, were reported for coronary artery myocytes.
K ϩ -induced vasodilation is an important physiological mechanism in the cerebral and coronary circulations but has not been studied in the renal circulation. Periods of high neural activity, such as seizure, and ischemic, hypoxic, or hypoglycemic conditions increase K ϩ levels in cerebral spinal fluid to Ͼ10 mmol/L. 26 The resultant K ϩ -induced dilation increases blood supply to areas of high metabolic demand. 14 Similarly, in the coronary circulation, interstitial K ϩ levels may rise during periods of ischemia to levels sufficient to activate K ϩ -induced dilation. 27 In the canine kidney, elevation of plasma [K ϩ ] to Ϸ10 mmol/L has been shown to increase renal blood flow (RBF) and glomerular filtration rate (GFR). 28 Similar effects of acute hyperkalemia on RBF and GFR have been reported in conscious sheep 29 and in rats 30 and rabbits. 31 Although these investigations did not consider the possible role of Kir, our finding that elevated K ϩ promotes afferent arteriolar vasodilation through Kir is consistent with the observed increase in RBF and GFR.
By modulating glomerular inflow resistance, the afferent arteriole regulates glomerular capillary pressure and GFR when renal perfusion pressure is altered. Pressure-induced afferent vasoconstriction mediates this effect. Our observation that Kir is a major determinant of RMP in this vessel prompted an investigation into the possible involvement of Kir in myogenic signaling. Our findings do not support this postulate. Thus, although Ba 2ϩ elicited membrane depolarization and vasoconstriction at low pressure, it did not prevent elevations in RAP from causing additional vasoconstriction. These data agree with findings from Kir2.1 knockout mice. 23 In this model, cerebral arteries showed normal myogenic reactivity but no K ϩ -induced dilation. The observed changes in myogenic responses, including a leftward shift in the myogenic threshold, likely reflect the increase in basal tone and more positive RMP in the presence of Ba 2ϩ .
Defining the determinants of RMP under physiological conditions is of critical importance in regard to potential activation mechanisms. Agonists have been shown to inhibit specific K ϩ channels in isolated myocytes. 10 -12 However, such mechanisms could contribute to physiological responses only if the affected K ϩ channel contributes to RMP in the intact setting. The model we used allowed direct assessment of RMP and contractions in the intact afferent arteriole in situ under physiological conditions in regard to perfusion and transmural pressure. Our findings clearly indicate that Kir is a primary determinant of RMP under these conditions. Our model requires the induction of hydronephrosis to visualize the microvasculature. This preparation is well characterized and exhibits responses that are not only comparable to those observed using other renal microvascular models 8,32 but also similar to those of the normal, intact kidney. 16, 33 Thus, there is no indication that hydronephrosis alters vascular K ϩ channel expression. Nevertheless, this possibility cannot be excluded. As described above, K ϩ -induced vasodilation is observed in the normal kidney, 28 -31 but the role of Kir in this response has not been investigated. Moreover, bariumsensitive K ϩ currents have not been studied in myocytes or endothelial cells of the afferent arteriole. Information on the expression and regulation of Kir in this vessel would be of major interest.
In conclusion, this study provides the first functional evidence for Kir in renal afferent arterioles. Our findings suggest that Kir is a major determinant of in situ RMP and resting tone in this vessel. Accordingly, alterations in Kir activity or expression would likely impact on renal microvascular reactivity and could contribute to physiological or pathophysiological alterations in renal hemodynamics.
